Literature DB >> 30001570

Determination of vortioxetine and its degradation product in bulk and tablets, by LC-DAD and MS/MS methods.

Marta de Diego1, Diana Correa1, Sigrid Mennickent1, Ricardo Godoy1, Carola Vergara1.   

Abstract

Vortioxetine hydrobromide (VOR), is a novel antidepressant used for the treatment of major depressive disorder. It has a chemical structure susceptible to degradation, therefore it is important to have suitable analytical methods to determine VOR in presence of its main degradation products (DP), because if the compound degrades, this could result in diminution of the therapeutic activity and safety. A simple HPLC method with photodiode array detection was developed and validated for determination of VOR in bulk and tablets, in the presence of its major DP. The drug was subjected to oxidative, hydrolytic, and photolytic stress conditions, showing significant degradation under oxidation with the formation of one DP, which was identified by ESI-MS/MS. A C18 column was used, with mobile phase consisting of acetonitrile and water with acetic acid and triethylamine in isocratic elution mode, with detection at 228 nm and 1.0 mL/min flow rate. The assay was linear in the 25-125 μg/mL concentration range. For precision, the RSD was <1.8%, the recovery was 100.0-101.6%, and the method demonstrated adequate selectivity. The method was successfully applied to quantify VOR in tablets. The results showed that the method is useful for routine analysis and for quality control purposes.
© 2018 John Wiley & Sons, Ltd.

Entities:  

Keywords:  degradation products; validation; vortioxetine

Mesh:

Substances:

Year:  2018        PMID: 30001570     DOI: 10.1002/bmc.4340

Source DB:  PubMed          Journal:  Biomed Chromatogr        ISSN: 0269-3879            Impact factor:   1.902


  4 in total

1.  Vortioxetine liposomes as a novel alternative to improve drug stability under stress conditions: toxicity studies and evaluation of antidepressant-like effect.

Authors:  Caroline Hermann Nodari; Natália Dalanhol De Quadros; Raquel Chiarentin; Francini Pereira Da Silva; Fernando Dal Pont Morisso; Mariele Feiffer Charão; Juliane Deise Fleck; Cristiane Bastos De Mattos; Andresa Heemann Betti; Simone Gasparin Verza
Journal:  Pharmacol Rep       Date:  2022-09-09       Impact factor: 3.919

2.  Comparison of Various Chromatographic Systems for Identification of Vortioxetine in Bulk Drug Substance, Human Serum, Saliva, and Urine Samples by HPLC-DAD and LC-QTOF-MS.

Authors:  Anna Petruczynik; Karol Wróblewski; Krzysztof Wojtanowski; Tomasz Mroczek; Dariusz Juchnowicz; Hanna Karakuła-Juchnowicz; Tomasz Tuzimski
Journal:  Molecules       Date:  2020-05-27       Impact factor: 4.411

3.  PVP-H2O2 Complex as a New Stressor for the Accelerated Oxidation Study of Pharmaceutical Solids.

Authors:  Dattatray Modhave; Brenda Barrios; Amrit Paudel
Journal:  Pharmaceutics       Date:  2019-09-03       Impact factor: 6.321

4.  Development of the Validated Stability-Indicating Method for the Determination of Vortioxetine in Bulk and Pharmaceutical Formulation by HPLC-DAD, Stress Degradation Kinetics Studies and Detection of Degradation Products by LC-ESI-QTOF-MS.

Authors:  Karol Wróblewski; Małgorzata Szultka-Młyńska; Daria Janiszewska; Anna Petruczynik; Bogusław Buszewski
Journal:  Molecules       Date:  2022-03-14       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.